Text Size
3712 studies found for:    Lung Diseases, Obstructive: Clinical trials

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Completed A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GW685698/GW642444
2 Completed Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Osteoporosis;   Chronic Obstructive Pulmonary Disease (COPD);   Osteopenia
Interventions: Drug: fluticasone propionate/salmeterol powder;   Drug: salmeterol powder
3 Recruiting Spontaneous Breathing Trials Using Pressure-Support or T-Tube in Chronic Obstructive Pulmonary Disease Patients Weaning Mechanical Ventilation
Conditions: Weaning of Mechanical Ventilation;   Chronic Obstructive Pulmonary Disease
Interventions: Procedure: "T" Tube Spontaneous Breathing Trial;   Procedure: Pressure Support Ventilation
4 Completed A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).
Conditions: COPD;   Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Collection of safety data for Cohort 1
5 Active, not recruiting The Chronic Obstructive Pulmonary Disease Fish Oil Pilot Trial
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Dietary Supplement: n-3 polyunsaturated fatty acids;   Other: Placebo
6 Completed Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Prednisolone
7 Enrolling by invitation European Quality of Care Pathways Study on Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Other: COPD evidence based care pathway
8 Recruiting Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Cardiovascular Disease
Interventions: Drug: fluticasone furoate/vilanterol;   Drug: fluticasone furoate;   Drug: vilanterol;   Other: Placebo
9 Completed
Has Results 		26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   COPD;   Lung Diseases, Obstructive
Interventions: Drug: Indacaterol;   Drug: Formoterol (12 µg b.i.d.);   Drug: Tiotropium (18 µg o.d.);   Drug: Placebo to Indacaterol;   Drug: Placebo to Formoterol
10 Completed A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 Days
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GSK573719
11 Completed Study to Investigate Daily Symptom Variability, Symptom Effects on Morning Activities of Chronic Obstructive Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
12 Completed 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK573719/GW642444 125/25;   Drug: GSK573719/GW642444 62.5/25;   Drug: GSK573719;   Drug: tiotropium bromide
13 Completed
Has Results 		Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Formoterol (OT)
14 Completed
Has Results 		Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: ADVAIR DISKUS 250/50 mg BID;   Drug: SEREVENT 50 mcg BID
15 Completed
Has Results 		1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Glycopyrronium bromide;   Drug: Placebo to glycopyrronium bromide;   Drug: Tiotropium
16 Not yet recruiting A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Umeclidinium bromide/Vilanterol;   Drug: Placebo ACCUHALER/DISKUS;   Drug: Fluticasone propionate/Salmeterol;   Drug: Placebo NDPI
17 Completed A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Chronic Obstructive Airway Disease
Interventions: Drug: GW856553;   Drug: Placebo;   Drug: Seretide
18 Active, not recruiting Long-term Safety Study for GSK573719/GW642444 in Japanese
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GSK573719/GW642444 Inhalation Powder
19 Completed A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
20 Completed Discharge Coordinator Intervention in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: Coordinated discharge;   Other: Control
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years